Description
Tradename:
Allerban SR
Compound:
Each tablet contains:
ketotifen fumarate 2 mg
Properties:
A stabilizer of mast cell membranes, it has moderate H1-histamine-blocking activity, inhibits the release of histamine, leukotrienes from basophils and neutrophils, reduces the accumulation of eosinophils in the respiratory tract and the reaction to histamine, suppresses early and late asthmatic reactions to the allergen. Prevents the development of bronchospasm, does not have a bronchodilator effect.
Indications:
atopic bronchial asthma;
hay fever (hay fever);
allergic rhinitis;
allergic conjunctivitis;
atopic dermatitis;
hives.
Directions for use and dosage:
Allerban SR extended-release tablets, due to their mechanism of action, need to be taken once a day.
Adults: 1 tablet in the evening.
For patients in whom the drug causes drowsiness or slow reaction, it is recommended to reduce the dose to 1/2 tablet at the beginning of treatment for 1 week. The maximum daily dose is 4 mg, taken in 2 divided doses.
Contraindications:
pregnancy;
lactation period;
children under 3 years of age;
hypersensitivity.
Precautionary measures:
Prescribed with caution for epilepsy and liver failure.
Abrupt cancellation of previous treatment with beta-adrenergic stimulants, glucocorticosteroids, adrenocorticotropic hormone (ACTH) in patients with bronchial asthma and bronchospastic syndrome after joining ketotifen therapy is undesirable; cancellation is carried out for at least 2 weeks.
Side effects:
Drowsiness, dizziness, slow reaction, dry mouth, increased appetite.
Storage method:
At a temperature not higher than 30 degrees.
